Evidence method
Level · gp.fundamentals.debt_to_revenue
20.43% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
AKBA · Dec 31, 2025
Akebia Therapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001517022-26-000020General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.12% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
28.79% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
47.46% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
6.61% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
83.29% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
9.95% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
26.40% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
4.78% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History12 statesHistory building
Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/9 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20250/9 normalizedLevel 3Sep 30, 20257/9 normalizedLevel 3Dec 31, 20257/9 normalizedLevel 3Mar 31, 20268/9 normalizedLevel 3Jun 30, 20268/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 81.07%
- Current
- 20.43%
- Delta
- -60.64%
- Previous
- 0.13%
- Current
- 0.12%
- Delta
- -0.01%
- Previous
- 47.83%
- Current
- 28.79%
- Delta
- -19.04%
- Previous
- 57.01%
- Current
- 47.46%
- Delta
- -9.55%
- Previous
- 31.72%
- Current
- 6.61%
- Delta
- -25.12%
- Previous
- 84.03%
- Current
- 83.29%
- Delta
- -0.74%
- Previous
- 7.57%
- Current
- 9.95%
- Delta
- 2.38%
- Previous
- 25.43%
- Current
- 26.40%
- Delta
- 0.97%
- Previous
- 5.48%
- Current
- 4.78%
- Delta
- -0.70%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · AKBA Fundamental State →Transitioned To · AKBA Fundamental State →Transitioned To · AKBA BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · AKBA CAPEX_INTENSITY_DECREASED →Transitioned To · AKBA CASH_GENERATION_DECREASED →Transitioned To · AKBA GROWTH_DECREASED →Transitioned To · AKBA INVENTORY_PRESSURE_DECREASED →Transitioned To · AKBA MARGIN_DECREASED →Transitioned To · AKBA PROFITABILITY_INCREASED →Transitioned To · AKBA R_AND_D_INTENSITY_INCREASED →Transitioned To · AKBA SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.